This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Perennial Allergic Rhinitis
and you are
between 18 and 60
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

The aim of this study is to investigate the short and long term efficacy and the safety of SCRT treatment for PAR

Provided treatments

  • Drug: SCRT
  • Drug: Placebos

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03009136. The sponsor of the trial is Kyung Hee University Hospital at Gangdong and it is looking for 154 volunteers for the current phase.
Official trial title:
Efficacy and Safety of So-Cheong-Ryong-Tang on Perennial Allergic Rhinitis: Study Protocol for a Double-blind, Randomized, Parallel-group, Multi-center Trial